Company introduced proprietary PluriFreeze™ cryopreservation system, in collaboration with Pluristyx, Inc. Company reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., May 08, 2025 ...
HOLLISTER, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of ...
(MENAFN- GlobeNewsWire - Nasdaq) HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of ...
Hosted on MSN
Teknova reiterates $39M–$42M 2025 revenue target while eyeing 20%–25% long-term growth amid operational advances
Teknova is "reiterating 2025 total revenue guidance of $39 million to $42 million." Lowell noted, "Based on persistent softness in demand for our Clinical Solutions products from biopharma customers, ...
HOLLISTER, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results